Several studies have now demonstrated that C3G, DP, and PCA effectively intervene in the NF-κB and MAPK signaling pathways through multiple mechanisms, thereby alleviating the inflammatory response in RA. The gene discussed is NFKB1; the disease is rheumatoid arthritis.